Adamiak et al. reported that NSE cannot be used to accurately monitor patients with HNSCC [37], while the CEA level was correlated with the clinical stage of tumor and could decline after resection [38]. This evidence concerns the gene CEACAM5 and head and neck squamous cell carcinoma.